Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ibuprofen Oral Powder vs Reference Products
NCT03018015Phase 1Completed
- Sponsor
- SocraTec R&D
- Start
- Sep 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain (3 arms), sponsored by SocraTec R&D. Primary endpoints: Area under the plasma concentration versus time curve from time zero to the last measurable concentration at 16 hours and Peak Plasma Concentration at 16 hours. Started Sep 2016; status: completed.
02
Drugs
ibuprofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT03018015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03018015.